Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review
This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are an efficient investment. This review further highlights key gaps in the available literature that would benefit from additional research, especially in the area of evaluating the broader economic benefits of vaccination in the developing world. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS
Visit web site (English)
(Located at www.sciencedirect.com)
Citation: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS. Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review. Vaccine. 2012;31(1):96-108.